Potent E. coli M-17 Growth Inhibition by Ultrasonically Complexed Acetylsalicylic Acid–ZnO–Graphene Oxide Nanoparticles-Reference-Cited by-同舟云学术

Potent E. coli M-17 Growth Inhibition by Ultrasonically Complexed Acetylsalicylic Acid–ZnO–Graphene Oxide Nanoparticles

Published:2021-01-07 Issue:1 Volume:4 Page:778-792
ISSN:2574-0970
Container-title:ACS Applied Nano Materials
language:en
Short-container-title:ACS Appl. Nano Mater.

Author:

Tkach Anastasia¹,Burko Aliaksandr²,Bandarenka Hanna²³,Khrustaleva Tatyana²⁴,Zhigulin Dmitry⁵,Tabulina Ljudmila¹,Labunov Vladimir¹,Veltruská Kateřina⁶,Matolín Vladimír⁶,Radziuk Darya¹^ORCID

Affiliation:

1. Laboratory of Integrated Micro- and Nanosystems, Belarusian State University of Informatics and Radioelectronics, P. Brovki Str. 6, 220013 Minsk, Republic of Belarus

2. Laboratory of Applied Plasmonics, Belarusian State University of Informatics and Radioelectronics, P. Brovki Str. 6, 220013 Minsk, Republic of Belarus

3. Polytechnic School, Arizona State University, 6075 S. Innovation Way, Mesa, Arizona 85212, United States

4. Biochemistry Group of Multidisciplinary Diagnostic Laboratory, Institute of Physiology, National Academy of Sciences of Belarus, Academicheskaya Str. 28, 220072 Minsk, Republic of Belarus

5. Scientific-Technical Center “Belmicrosystems”, Kazintsa Str. 121 A, 220108 Minsk, Republic of Belarus

6. Department of Surface and Plasma Science, Charles University, V Holešovičkách 2, 18000 Prague 8, Czech Republic

Funder

Belarusian Republican Foundation for Fundamental Research

MOST Belarus-EU

Structure fund project

CERIC-ERIC

Publisher

American Chemical Society (ACS)

Subject

General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsanm.0c03111

Reference69 articles.

1. Escherichia colistrain Nissle 1917—from bench to bedside and back: history of a specialEscherichia colistrain with probiotic properties

2. Association of phylogenetic distribution and presence of integrons with multidrug resistance in Escherichia coli clinical isolates from children with diarrhoea

3. In vitro and in vivo effects of the probiotic Escherichia coli strain M-17: immunomodulation and attenuation of murine colitis

4. Regulating the Safety of Probiotics - The European Approach